Skip to main content
C

China Meheco Group Co., Ltd. — Investor Relations & Filings

Ticker · 600056 LEI · 300300PBRRWGVD4VNQ86 Shanghai Stock Exchange Wholesale and retail trade
Filings indexed 2,098 across all filing types
Latest filing 2026-01-21 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600056

About China Meheco Group Co., Ltd.

China Meheco Group Co., Ltd. is a comprehensive healthcare enterprise integrated into the global pharmaceutical supply chain. The company operates across the entire industrial spectrum, including research and development, cultivation of medicinal herbs, pharmaceutical manufacturing, international trade, and technical services. Its core business segments encompass the production and distribution of active pharmaceutical ingredients (APIs), finished medicines, medical devices, and traditional Chinese medicine. The organization leverages an extensive logistics network and retail pharmacy presence to facilitate healthcare delivery. By maintaining strategic partnerships and a robust international trade platform, the company provides integrated solutions for medical procurement and supply chain management. Its operations focus on ensuring the quality and accessibility of healthcare products through a vertically integrated business model that spans from raw material sourcing to end-user distribution.

Recent filings

Filing Released Lang Actions
关于回复购买资产有关事项监管工作函的公告
Regulatory Filings
2026-01-21 Chinese
关于召开购买资产有关事项的投资者说明会的公告
Regulatory Filings
2026-01-21 Chinese
关于子公司药品通过仿制药一致性评价的公告
Regulatory Filings
2026-01-16 Chinese
关于向专业投资者公开发行公司债券获得注册批复的公告
Regulatory Filings
2026-01-12 Chinese
关于子公司获得药品注册证书的公告
Regulatory Filings
2026-01-08 Chinese
关于子公司收到《税务事项通知书》暨补缴税款相关事项的公告
Regulatory Filings
2025-12-31 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.